SRPT sarepta.com Revenue Growth QoQ

Corporate emblem and logo of Sarepta Therapeutics Inc (SRPT)

The reliability of Sarepta Therapeutics, Inc. (SRPT) is guaranteed by competent management successfully commercializing innovations in gene therapy. This quarterly revenue growth chart confirms this resilience, where the metric stands at -4.40. The business relies on absolute patient loyalty and FDA approvals, while a flawless cold chain ensures the secure delivery of complex biologics to clinics.

SRPT (Sarepta Therapeutics Inc) Quarterly Revenue Growth history from 07/04/2022 to 11/21/2026

Analytical breakdowns and data insights for company Sarepta Therapeutics Inc (SRPT)

- stock price and consensus target price:
Analysis of all company metrics:Sarepta Therapeutics Inc - SRPT
Manufactured products of Sarepta Therapeutics

The specifics of Sarepta Therapeutics, Inc. (SRPT) and its reliance on CMO outsourcing make cash flow dependent on the efficiency of external vendors and patent protection. This quarterly revenue growth metric converts the percentage change in operating income into a daily trajectory, allowing investors to assess real-time sales dynamics and the resilience of the company's business model amid shifting market cycles.

Who Sarepta Therapeutics, Inc. competes with

TEM - Revenue Growth QoQ|Quarterly Sales Growth Rate qiagen.com QGEN|IONS: Quarterly Revenue Growth|Repligen Corp - Quarterly Revenue Increase|RNA (Avidity Corp) - Quarterly Revenue Growth|CRISPR Therapeutics Corp - Revenue Dynamics QoQ|Revenue Growth QoQ genedx.com (WGS)|Quarterly Revenue Growth ultragenyx.com (RARE)|Quarterly Revenue Growth BEAM (Beam Therapeutics Inc)|TWST - Quarterly Sales Growth|TXG: Quarterly Sales Growth|Quarterly Revenue Growth Rate Intellia Therapeutics|STOK: Quarterly Revenue Growth|BLFS - Quarterly Sales Growth Rate|Quarterly Sales Growth WVE|MAZE: Quarterly Revenue Increase|Revenue Growth QoQ Sionna Corp (SION)|Quarterly Sales Growth Rate Prime Medicine Bio|Quarterly Revenue Growth TSHA (Taysha Gene Therapies Inc)|Quarterly Revenue Growth uniqure.com QURE|MeiraGTx Holdings - Quarterly Revenue Growth|RGNX - Quarterly Revenue Growth|SLDB (Solid Corp) - Quarterly Sales Growth|Revenue Change vs Previous Quarter Ocugen Corp OCGN|PACB (Pacific Biosciences) - Quarterly Revenue Growth|Revenue Growth QoQ BNTC|Quarterly Revenue Growth DSGN|Quarterly Sales Growth Rocket Pharma RCKT|Quarterly Sales Growth Rate FDMT|Quarterly Revenue Growth Lexeo Therapeutics LXEO|KRRO - Revenue Growth QoQ|EDIT (Editas Medicine, Inc.) - Sales Growth QoQ|SLN: Quarterly Revenue Growth|ProQR - Quarterly Revenue Increase|CDXS (Codexis) - Quarterly Revenue Growth|Sangamo (SGMO) - Quarterly Sales Growth Rate|Quarterly Revenue Growth NAUT|Quarterly Sales Growth Metagenomi, Inc. MGX|Revenue Growth QoQ Precision BioSciences DTIL|Quarterly Revenue Increase GBIO|BOLD - Revenue Growth QoQ|Quarterly Sales Growth Rate Exicure Inc. XCUR|Imunon, Inc. (IMNN) - Revenue Growth QoQ|RXi Pharmaceuticals - Quarterly Revenue Increase|MBIO (Mustang Bio) - Quarterly Revenue Growth|Sales Growth QoQ RNAZ (transcodetherapeutics.com)|Revenue Growth QoQ Bionano (BNGO)|Applied DNA Sciences - Sales Growth QoQ|Quarterly Revenue Growth BLUE (bluebirdbio.com)|ImmunoPrecise Antibodies (IPA) - Quarterly Revenue Growth Rate|omegatherapeutics.com - Quarterly Revenue Growth|Revenue Change vs Previous Quarter Singular Genomics Systems Inc (OMIC)|RGLS: Quarterly Revenue Growth|Syros Pharmaceuticals, Inc (SYRS) - Quarterly Revenue Growth|TBIO (telesisbio.com) - Quarterly Revenue Growth|TCON: Quarterly Revenue Increase|Revenue Growth QoQ Unity Biotechnology, Inc (UBX)